Neurologist paid up to $20,000 a year by biotech companies removed from FDA dementia panel : vimarsana.com

Dr David Weisman, from Pennsylvania, was an advisor to two controversial Alzheimer's drug developers while also being on an FDA committee analyzing Alzheimer's drugs.

Related Keywords

Stanford University , California , United States , Pennsylvania , Georgetown University , District Of Columbia , Washington , Seema Yasmin , David Weisman , Christopher Van Dyck , Drug Administration , Abington Neurological Associates , Yale Alzheimer Disease Research Unit , Central Nervous System Drugs Advisory Committee , Yale Medicine , Disease Research Unit , Leticia Bode , Dailymail , Health , Alzheimers Disease , Fda ,